INNORA PTYRONE 30 CAPSULE

PtyroneTM is an oral anti-hyperglycemic formulation derived from a combination of two standardized plant extracts. Developed using novel FMNE technology

PtyroneTM is a Patented formulation

Standardization of the plants extracts with respect to the phytoactives for the biological activity.

IN SILICO STUDY DEMONSTRATE

As Peroxisome proliferator-activated

Receptor gamma activator

Glycogen synthase kinase 3 beta (GSK) inhibitor,

5’ AMP-activated protein kinase (AMPK) Up regulator,

Glut 4 up regulator

Sodium-Glucose transport protein 2 (SGLT2) inhibitors, (Published in high-impact International journal)

STZ model shows a statistically significant reduction in the blood glucose levels from Metformin and Diabetes control group

(Published in high impact international journal).

In Human clinical study conducted over 115 treated but uncontrolled patients shows that PtyroneTM when added to the other regular OHA’s such as Metformin, Metformin + Sulphonylureas and Metformin + Gliptins, shows:

Reduction in the post-prandial glucose by 33%

Fasting blood glucose by 30%

Reduction in HbA1c of about 0.4%

The patients reported no episode of hypoglycemia during this period.

A 24% reduction in total triglycerides was also reported.

PtyroneTM has been given to more than 1000 subjects to date and has been found to be very effective in reducing blood sugar levels.